Lixisenatide: Gastrointestinal: acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists under-going elective surgeries or procedures requiring general anesthesia or deep sedation
Estimates suggest that if Medicare were to cover Ozempic for weight loss, it could cost the program $14 billion to $27 billion per year, or about 3% of Medicares 2022 spending
Women with PCOS face unique hurdles when it comes to weight management on GLP-1 medications: One of the most powerful tools for overcoming plateaus is optimizing your nutrition approach
If you have to pay out of pocket, some drug companies offer discount programs
Vilsbll T, Bain SC, Leiter LA et al (2018) Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy